Investigators ID Predictors of CKD Progression After Radical Nephrectomy
Kidney microstructural features appear predictive of progressive CKD and mortality following radical nephrectomy.
All articles by Natasha Persaud
EAU Issues Updated UTUC Guidelines
The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Darolutamide Prolongs Overall Survival in nmCRPC
Darolutamide also improved secondary endpoints, including the time to pain progression, cytotoxic chemotherapy, and first symptomatic skeletal event.
Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
PN Risks May Outweigh Benefits in Some CKD Cases
Investigators highlight the importance of preoperative renal biopsy to rule out an indolent or benign tumor in patients with stage 4 CKD.
New Tool May Enable Less Intensive Prostate Cancer Active Surveillance
The model, based on routinely collected clinical characteristics, provides information that can enhance discussions between health care professionals and patients on active surveillance intensity.
Complete Metastasectomy Found to Prolong Survival in mRCC
A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not.
Mature Data Confirm Enzalutamide Survival Benefit in mCRPC
The latest analyses found 5-year overall survival benefits across low-, intermediate-, and high-risk subgroups of men with chemotherapy-naïve metastatic castration-resistant prostate cancer.
Priorities in Prostate Cancer Care During the Pandemic
The authors of a new review discuss priorities, adjustments, and tailored approaches to prostate cancer management during the COVID-19 pandemic.
Study Validates 3-Tiered Subclassification of High-Risk Prostate Cancer
The new stratification model may aid treatment decision-making for men with “favorable,” high-risk, or “very” high-risk prostate cancer.
-
Loading...
-
Loading...
Next post in Prostate Cancer
